Aptose Biosciences, Inc. (APS.TO)
2.33
-0.01
(-0.43%)
CAD |
TSX |
May 15, 16:00
Aptose Biosciences Shareholders Equity (Quarterly) : -48.39M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Resverlogix Corp. | -121.94M |
| Microbix Biosystems, Inc. | 25.14M |
| Helix BioPharma Corp. | 15.36M |
| COSCIENS Biopharma, Inc. | 21.38M |
| Atlas Energy Corp. | 26.01M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.96M |
| Total Liabilities (Quarterly) | 63.35M |
| Debt to Equity Ratio | -0.9874 |
| Current Ratio | 0.5476 |
| Net Debt Paydown Yield | -109.2% |